These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7875151

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
    Garavelli PL, Berti P.
    Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Montero MC, Pastor M, Buenestado C, Lluch A, Atienza M.
    Ann Pharmacother; 1996; 30(7-8):717-23. PubMed ID: 8826547
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
    Davey RT, Davey VJ, Metcalf JA, Zurlo JJ, Kovacs JA, Falloon J, Polis MA, Zunich KM, Masur H, Lane HC.
    J Infect Dis; 1991 Jul; 164(1):43-52. PubMed ID: 1676045
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Haematopoietic growth factors as supportive therapy in HIV-infected patients.
    Hermans P.
    AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.
    Hewitt RG, Morse GD, Lawrence WD, Maliszewski ML, Santora J, Bartos L, Bonnem E, Poiesz B.
    Antimicrob Agents Chemother; 1993 Mar; 37(3):512-22. PubMed ID: 8460920
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancer.
    Weiss GR, Shaffer DW, DeMoor C, Rinaldi DA, Rodriguez GI, Eckardt JR, Stephens C, Von Hoff DD.
    Anticancer Drugs; 1996 Jun; 7(4):402-9. PubMed ID: 8826608
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
    Squires KE.
    AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
    [Abstract] [Full Text] [Related]

  • 18. Hematopoietic growth factors as adjuncts to antiretroviral therapy.
    Miles SA.
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1073-80. PubMed ID: 1380256
    [Abstract] [Full Text] [Related]

  • 19. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
    Studies of Ocular Complications of AIDS Research Group. The AIDS Clinical Trials Group..
    Am J Ophthalmol; 2001 Apr; 131(4):457-67. PubMed ID: 11292409
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
    Danner SA, Matheron S.
    AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.